arXiv.itsnick.co

an independent field guide to 23 million papers from arXiv & OpenAlex — not affiliated with arXiv.org

Author

Josef Scheiber

14 papers · 2007–2017

2007: 32008: 32009: 62010: 02011: 02012: 02013: 02014: 02015: 02016: 12017: 1
2007peak 6 in 20092017

Frequent co-authors

Papers

showing 1–14 of 14 RSS

Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off‐Target Effects from Chemical Structure

Andreas Bender, Josef Scheiber, Meir Glick +6 more

Computational Theory and Mathematics · ChemMedChem · · cited 326× · DOI ↗ · more like this ·

Preclinical Safety Pharmacology (PSP) attempts to anticipate adverse drug reactions (ADRs) during early phases of drug discovery by testing compounds in simple, in vitro binding assays (that is, preclinical profiling). The selection of PSP targets is based largely on circumstantial evidence of their contribution to known clinical ADRs, inferred from findings in clinical trials, animal experiments, and molecular studies going back more than forty years. In this work we explore PSP chemical space and its relevance for the prediction of adverse drug reactions. Firstly, in silico (computational) Bayesian models for 70 PSP-related targets were built, which are able to detect 93% of the ligands binding at IC(50) < or = 10 microM at an overall correct classification rate of about 94%. Secondly, employing the World Drug Index (WDI), a model for adverse drug reactions was built directly based on…

How Similar Are Similarity Searching Methods? A Principal Component Analysis of Molecular Descriptor Space

Andreas Bender, Jeremy L. Jenkins, Josef Scheiber +3 more

Computational Theory and Mathematics · Journal of Chemical Information and Modeling · · cited 304× · DOI ↗ · more like this ·

Different molecular descriptors capture different aspects of molecular structures, but this effect has not yet been quantified systematically on a large scale. In this work, we calculate the similarity of 37 descriptors by repeatedly selecting query compounds and ranking the rest of the database. Euclidean distances between the rank-ordering of different descriptors are calculated to determine descriptor (as opposed to compound) similarity, followed by PCA for visualization. Four broad descriptor classes are identified, which are circular fingerprints; circular fingerprints considering counts; path-based and keyed fingerprints; and pharmacophoric descriptors. Descriptor behavior is much more defined by those four classes than the particular parametrization. Using counts instead of the presence/absence of fingerprints significantly changes descriptor behavior, which is crucial for…

Mapping Adverse Drug Reactions in Chemical Space

Josef Scheiber, Jeremy L. Jenkins, Sai Chetan K. Sukuru +9 more

Computational Theory and Mathematics · Journal of Medicinal Chemistry · · cited 159× · DOI ↗ · more like this ·

We present a novel method to better investigate adverse drug reactions in chemical space. By integrating data sources about adverse drug reactions of drugs with an established cheminformatics modeling method, we generate a data set that is then visualized with a systems biology tool. Thereby new insights into undesired drug effects are gained. In this work, we present a global analysis linking chemical features to adverse drug reactions.

Gaining Insight into Off-Target Mediated Effects of Drug Candidates with a Comprehensive Systems Chemical Biology Analysis

Josef Scheiber, Bin Chen, Mariusz Milik +9 more

Computational Theory and Mathematics · Journal of Chemical Information and Modeling · · cited 154× · DOI ↗ · more like this ·

We present a workflow that leverages data from chemogenomics based target predictions with Systems Biology databases to better understand off-target related toxicities. By analyzing a set of compounds that share a common toxic phenotype and by comparing the pathways they affect with pathways modulated by nontoxic compounds we are able to establish links between pathways and particular adverse effects. We further link these predictive results with literature data in order to explain why a certain pathway is predicted. Specifically, relevant pathways are elucidated for the side effects rhabdomyolysis and hypotension. Prospectively, our approach is valuable not only to better understand toxicities of novel compounds early on but also for drug repurposing exercises to find novel uses for known drugs.

Understanding False Positives in Reporter Gene Assays:  in Silico Chemogenomics Approaches To Prioritize Cell-Based HTS Data

Thomas J. Crisman, Christian N. Parker, Jeremy L. Jenkins +8 more

Computational Theory and Mathematics · Journal of Chemical Information and Modeling · · cited 65× · DOI ↗ · more like this ·

High throughput screening (HTS) data is often noisy, containing both false positives and negatives. Thus, careful triaging and prioritization of the primary hit list can save time and money by identifying potential false positives before incurring the expense of followup. Of particular concern are cell-based reporter gene assays (RGAs) where the number of hits may be prohibitively high to be scrutinized manually for weeding out erroneous data. Based on statistical models built from chemical structures of 650 000 compounds tested in RGAs, we created "frequent hitter" models that make it possible to prioritize potential false positives. Furthermore, we followed up the frequent hitter evaluation with chemical structure based in silico target predictions to hypothesize a mechanism for the observed "off target" response. It was observed that the predicted cellular targets for the frequent…

Which aspects of HTS are empirically correlated with downstream success?

Andreas Bender, Dejan Bojanic, John Davies +9 more

Computational Theory and Mathematics · PubMed · · cited 48× · OpenAlex ↗ · more like this ·

High-throughput screening (HTS) is a well-established hit-finding approach used in the pharmaceutical industry. In this article, recent experience at Novartis with respect to factors influencing the success of HTS campaigns is discussed. An inherent measure of HTS quality could be defined by the assay Z and Z' factors, the number of hits and their biological potencies; however, such measures of quality do not always correlate with the advancement of hits to the later stages of drug discovery. Also, for many target classes, such as kinases, it is easy to identify hits, but, as a result of selectivity, intellectual property and other issues, the projects do not result in lead declarations. In this article, HTS success is defined as the fraction of HTS campaigns that advance into the later stages of drug discovery, and the major influencing factors are examined. Interestingly, screening…

“Virtual Fragment Linking”: An Approach To Identify Potent Binders from Low Affinity Fragment Hits

Thomas J. Crisman, Andreas Bender, Mariusz Milik +7 more

Computational Theory and Mathematics · Journal of Medicinal Chemistry · · cited 42× · DOI ↗ · more like this ·

In this work we explore the possibilities of using fragment-based screening data to prioritize compounds from a full HTS library, a method we call virtual fragment linking (VFL). The ability of VFL to identify compounds of nanomolar potency based on micromolar fragment binding data was tested on 75 target classes from the WOMBAT database and succeeded in 57 cases. Further, the method was demonstrated for seven drug targets from in-house screening programs that performed both FBS of 8800 fragments and screens of the full library. VFL captured between 28% and 67% of the hits (IC 50 < 10microM) in the top 5% of the ranked library for four of the targets (enrichment between 5-fold and 13-fold). Our findings lead us to conclude that proper coverage of chemical space by the fragment library is crucial for the VFL methodology to be successful in prioritizing HTS libraries from fragment-based…

Side effect profile prediction - early addressing of big pharma's worst nightmare

Josef Scheiber, James L. Jenkins, Andreas Bender +6 more

Computational Theory and Mathematics · Chemistry Central Journal · · cited 28× · DOI ↗ · more like this ·

Adverse effects of drugs that are only identified after a compound enters the clinic seriously limit therapeutic potential and could result in withdrawal from the market.Two well-known examples in recent years were Rofecoxib (Vioxx®) and Cerivastatin (Baycol®, Lipobay®), but there are many other examples.Avoiding such adverse effects is therefore a key goal in drug discovery.

Use of Ligand Based Models for Protein Domains To Predict Novel Molecular Targets and Applications To Triage Affinity Chromatography Data

Andreas Bender, Д. А. Михайлов, Meir Glick +8 more

Computational Theory and Mathematics · Journal of Proteome Research · · cited 18× · DOI ↗ · more like this ·

The elucidation of drug targets is important both to optimize desired compound action and to understand drug side-effects. In this study, we created statistical models which link chemical substructures of ligands to protein domains in a probabilistic manner and employ the model to triage the results of affinity chromatography experiments. By annotating targets with their InterPro domains, general rules of ligand-protein domain associations were derived and successfully employed to predict protein targets outside the scope of the training set. This methodology was then tested on a proteomics affinity chromatography data set containing 699 compounds. The domain prediction model correctly detected 31.6% of the experimental targets at a specificity of 46.8%. This is striking since 86% of the predicted targets are not part of them (but share InterPro domains with them), and thus could not…

xMaP—An Interpretable Alignment-Free Four-Dimensional Quantitative Structure–Activity Relationship Technique Based on Molecular Surface Properties and Conformer Ensembles

Jan Dreher, Josef Scheiber, Nikolaus Stiefl +1 more

Computational Theory and Mathematics · Journal of Chemical Information and Modeling · · cited 17× · DOI ↗ · more like this ·

A novel alignment-free molecular descriptor called xMaP (flexible MaP descriptor) is introduced. The descriptor is the advancement of the previously published translationally and rotationally invariant three-dimensional (3D) descriptor MaP (mapping property distributions onto the molecular surface) to the fourth dimension (4D). In addition to MaP, xMaP is independent of the chosen starting conformation of the encoded molecules and is therefore entirely alignment-free. This is achieved by using ensembles of conformers, which are generated by conformational searches. This step of the procedure is similar to Hopfinger's 4D quantitative structure-activity relationship (QSAR). A five-step procedure is used to compute the xMaP descriptor. First, a conformational search for each molecule is carried out. Next, for each of the conformers an approximation to the molecular surface with equally…

Chemogenomic Analysis of Safety Profiling Data

Josef Scheiber, Jeremy L. Jenkins

Computational Theory and Mathematics · Methods in molecular biology · · cited 8× · DOI ↗ · more like this ·

Understanding the safety of newly developed compounds is a key task in each early drug discovery project. In early stages, pharmaceutical companies address this task by using so-called preclinical safety profiling, in which compounds are screened in inexpensive large-scale assays to understand possible liabilities. This process generates a large amount of binding data on various compounds against a panel of targets - usually thousands or tens of thousands of compounds profiled against approximately 100 different targets. This data matrix is highly valuable and elicits further analysis. After briefly introducing the nature of safety profiling data, we describe several computational methods used internally at Novartis to analyze it. We showcase protocols that can be used to understand compound promiscuity on a chemical structure level and protocols to evaluate the promiscuity of targets…

SPREAD—exploiting chemical features that cause differential activity behavior

Josef Scheiber, Jeremy L. Jenkins, Andreas Bender +8 more

Computational Theory and Mathematics · Statistical Analysis and Data Mining The ASA Data Science Journal · · cited 1× · DOI ↗ · more like this ·

Abstract We present a novel generic method to better understand the divergent activities of molecules that often occur in orthogonal assays. The newly developed simple prediction of activity differences (SPREAD) method directly aims to model and understand the differences compounds exhibit when tested in two or more assays. By transforming the activity values from the assays into meta‐categories (specifically defined for datasets under scrutiny), statistical models can be trained directly on the qualitative differences between assays. This contributes heavily toward a tangible understanding of molecular assay selectivity. Although ensembles of models could be used alternatively to predict compounds that score highly in one assay and low in another, the advantage of the SPREAD approach is that the chemical features influencing assay differences are parsed out immediately as a consequence…

Use of Ligand Based Models for Protein Domains To Predict Novel Molecular Targets and Applications To Triage Affinity Chromatography Data

Andreas Bender (192334), Dmitri Mikhailov (2375062), Meir Glick (118497) +8 more

Computational Theory and Mathematics · Figshare · · cited 0× · DOI ↗ · more like this ·

The elucidation of drug targets is important both to optimize desired compound action and to understand drug side-effects. In this study, we created statistical models which link chemical substructures of ligands to protein domains in a probabilistic manner and employ the model to triage the results of affinity chromatography experiments. By annotating targets with their InterPro domains, general rules of ligand−protein domain associations were derived and successfully employed to predict protein targets &lt;i&gt;outside&lt;/i&gt; the scope of the training set. This methodology was then tested on a proteomics affinity chromatography data set containing 699 compounds. The domain prediction model correctly detected 31.6% of the experimental targets at a specificity of 46.8%. This is striking since 86% of the predicted targets are not part of them (but share InterPro domains with them)…

Side effect profile prediction - Tackling Big Pharma's worst nightmare at an early stage

Josef Scheiber

Computational Theory and Mathematics · Nature Precedings · · cited 0× · DOI ↗ · more like this ·

Abstract This talk presents a method that predicts adverse side effects for molecules based on the chemical structure only. Also, targets for the compounds are predicted. Therefore it becomes possible to link a certain side effect to the interaction with a certain target through molecular space. Examples are given in the talk.